These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 7540730)

  • 21. Prevention of posttransfusion hepatitis B and C by screening for antibody to hepatitis C virus and antibody to HBcAg.
    Chung HT; Lee JS; Lok AS
    Hepatology; 1993 Nov; 18(5):1045-9. PubMed ID: 7693569
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatitis C virus antibodies in patients on hemodialysis.
    San Miguel G; Crespo J; Echevarria S; D'Francisco A; Gomez Ullate P; Pons Romero F
    Infect Control Hosp Epidemiol; 1992 May; 13(5):254, 256. PubMed ID: 1375612
    [No Abstract]   [Full Text] [Related]  

  • 23. Hepatitis C virus screening and clinical monitoring of biomarkers in patients undergoing hemodialysis.
    Maia LP; Martins-Filho OA; Teixeira-Carvalho A; Speziali E; Vermhren R; Lira EF; Lima TA; Braga WS; Torres KL; Malheiro A
    J Med Virol; 2009 Jul; 81(7):1220-31. PubMed ID: 19475604
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Viral hepatitis in hemodialysis patients].
    Yanai M
    Rinsho Byori; 2001 Mar; 49(3):249-53. PubMed ID: 11307324
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of a total core antigen assay for the diagnosis of hepatitis C virus infection in hemodialysis patients.
    Bouzgarrou N; Fodha I; Othman SB; Achour A; Grattard F; Trabelsi A; Pozzetto B
    J Med Virol; 2005 Dec; 77(4):502-8. PubMed ID: 16254976
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of antibodies to HCV in haemodialysis patients using two second generation ELISA tests.
    Dentico P; Volpe A; Buongiorno R; Fiore G; Carbone M; Manno C; Pastore G; Schiraldi O
    Ital J Gastroenterol; 1993 Jan; 25(1):19-22. PubMed ID: 7679012
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence of hepatitis C virus antibody in patients on chronic hemodialysis.
    Nomiyama K; Tsuji H; Ikeda K; Kawatoko T; Kashiwagi S; Nakamura S; Fujishima M
    Fukuoka Igaku Zasshi; 1998 Aug; 89(8):232-7. PubMed ID: 9778915
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Markers of hepatitis C virus infection in dialysis units. A decreasing problem but still present in Argentina].
    Bruch Igartúa E
    Acta Gastroenterol Latinoam; 1999; 29(3):135-7. PubMed ID: 10533661
    [No Abstract]   [Full Text] [Related]  

  • 29. Hepatitis C infection in dialysis patients in Israel.
    Weinstein T; Tur-Kaspa R; Chagnac A; Korzets A; Ori Y; Zevin D; Herman M; Gafter U
    Isr Med Assoc J; 2001 Mar; 3(3):174-7. PubMed ID: 11303373
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Changes in antibodies to specific hepatitis C virus antigens with interferon-alpha therapy: analysis by recombinant immunoblot assay.
    Yuki N; Hayashi N; Hagiwara H; Takehara T; Katayama K; Kasahara A; Fusamoto H; Kamada T
    Am J Gastroenterol; 1993 Jun; 88(6):914-8. PubMed ID: 7684885
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnostic utility of hepatitis C virus core antigen in hemodialysis patients.
    Medhi S; Potukuchi SK; Polipalli SK; Swargiary SS; Deka P; Chaudhary A; Begum N; Hussain Z; Ahlawat RS; Kar P
    Clin Biochem; 2008 May; 41(7-8):447-52. PubMed ID: 18267117
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evidence of transmission of hepatitis C by hemodialysis.
    Sungur C; Ozkuyumcu C; Ozen S; Yasavul U; Turgan C; Caglar S
    Nephron; 1993; 64(2):313. PubMed ID: 7686637
    [No Abstract]   [Full Text] [Related]  

  • 33. Evidence against transmission of hepatitis C virus through hemodialysis ultrafiltrate and peritoneal fluid.
    Caramelo C; Navas S; Alberola ML; Bermejillo T; Reyero A; Carreño V
    Nephron; 1994; 66(4):470-3. PubMed ID: 7517019
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is dialysis environment more important than blood transfusion in transmission of hepatitis C virus during hemodialysis?
    Kapoor M; el-Reshaid K; al-Mufti S; Sanad NA; Koshy A
    Vox Sang; 1993; 65(4):331. PubMed ID: 7508661
    [No Abstract]   [Full Text] [Related]  

  • 35. IgM antibodies to hepatitis C virus and haemodialysis patients.
    Navarro JF; Teruel J; Mateos M; Ortuño J
    Nephrol Dial Transplant; 1994; 9(8):1211. PubMed ID: 7528362
    [No Abstract]   [Full Text] [Related]  

  • 36. Hepatitis C virus.
    Tripathi S; Shetty KJ
    J Assoc Physicians India; 1992 May; 40(5):316-21. PubMed ID: 1282917
    [No Abstract]   [Full Text] [Related]  

  • 37. [Comparison of two commercial techniques for the identification of hepatitis C virus antibodies, RIBA and MATRIX].
    Bruguera M; Vidal J; Sánchez Tapias JM
    Med Clin (Barc); 1994 Apr; 102(15):598. PubMed ID: 7514703
    [No Abstract]   [Full Text] [Related]  

  • 38. Transmission of hepatitis C virus--route, dose, and titer.
    Alter MJ
    N Engl J Med; 1994 Mar; 330(11):784-6. PubMed ID: 8107747
    [No Abstract]   [Full Text] [Related]  

  • 39. [Infection route of non-transfused type C hepatitis].
    Tanaka E; Furuta S
    Nihon Rinsho; 1991 Feb; 49(2):351-6. PubMed ID: 1849193
    [No Abstract]   [Full Text] [Related]  

  • 40. The prevalence of antibody to hepatitis C virus in a dialysis population.
    Hay NM; Lynn KL; Schousboe MI
    N Z Med J; 1992 Apr; 105(931):134. PubMed ID: 1373230
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.